Skip to main navigationSkip to main content
The University of Southampton
We're launching a new website soon and would love your feedback. See the new design

Research project: Rapid Diagnosis of Allergy to Drugs using a Microfluidic Platform

Currently Active: 

Allergy to drugs is a category of adverse drug reaction (ADR) and affect 7%1 of the population and often result in hospitalisation. The current problem clinicians are facing is that it is difficult to diagnose drug allergy in patients as allergic mediators are often released and broken down before tests can be conducted. This is a predominant issue as false diagnosis can lead to the avoidance of a drug of choice and can lead to drugs being taken off the market. Therefore an accurate way of testing and predicting diagnosis of allergy to drugs is required.  

The current gold standard for diagnosing allergy is through a Dose Provocation Test, which, involves administering the patient with the suspected drug, which patients are often apprehensive to do. In addition these tests often give false positives and have the risk of provoking an anaphylactic reaction putting the patient at risk. The alternative is testing blood samples and exposing blood to allergen and measuring inflammatory mediators. However, the process requires expensive equipment, large volumes of blood and a large time window. Because of this, a study into creating a rapid test to determine drug allergy would be extremely beneficial.

Associated research themes

Engineering and the Environment

Biological Sciences

Faculty of Medicine

Related research groups

Clinical and Experimental Sciences
Bioengineering Science
Share this research project Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings